Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25190743 | 0.87 | IDO1 (0.55) | TDP1IDO1NPC1RAB9AFFAR1 | |
| SCHEMBL3036323 | 0.81 | CA1 (0.47) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL766905 | 0.77 | SMN1; SMN2 (0.44) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL9911294 | 0.77 | SMN1; SMN2 (0.44) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL251775 | 0.77 | IDO1 (0.40) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL997761 | 0.76 | TSHR (0.52) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL4455430 | 0.76 | CA1 (0.42) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL11526340 | 0.76 | CA1 (0.42) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL38650984 | 0.76 | CA1 (0.42) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL10629421 | 0.74 | CA1 (0.41) | TDP1CA1CA2CA9IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0185526-B1 | SOLVENT SOLUBLE FLUORINE-CONTAINING POLYMER, COATING COMPOSITION CONTAINING THE SAME AND COATING PROCESS THEREOF | MITSUI SEKIYU KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-03-13 | — | — | EP | claimed |
| US-4737444-A | UNDERCOATING IS POLYMER CONTAINING METAL ALCOHOLATE | RICOH COMPANY, LTD. (JP) | 1988-04-12 | — | — | US | claimed |
| CN-107049842-A | The Solic cosmetic composition of compacted powder form | 莱雅公司 | 2017-08-18 | — | — | CN | disclosed |
| US-9587206-B2 | Combination of an amino alcohol, a fragrance and a silicic acid ester, and the use of same as a pro-fragrance | HENKEL AG & CO. KGAA (DE) | 2017-03-07 | — | — | US | disclosed |
| CN-102421483-B | Cosmetic composition comprising a dye, said dye and cosmetic treatment method | L'OREAL (FR) | 2016-06-01 | — | — | CN | disclosed |
| US-20140323375-A1 | COMBINATION OF AN AMINO ALCOHOL, A FRAGRANCE AND A SILICIC ACID ESTER, AND THE USE OF SAME AS A PRO-FRAGRANCE | HENKEL AG & CO. KGAA (DE) | 2014-10-30 | — | — | US | disclosed |
| CN-101617998-B | Cosmetic or dermatological composition comprising a compound capable of creating hydrogen bonds, and cosmetic treatment method | OREAL FR | 2014-06-25 | — | — | CN | disclosed |
| CN-102421483-A | Cosmetic composition comprising a dye, said dye and cosmetic treatment method | OREAL | 2012-04-18 | — | — | CN | disclosed |
| CN-101617998-A | Cosmetic or dermatological composition comprising a compound capable of creating hydrogen bonds, and cosmetic treatment method | OREAL | 2010-01-06 | — | — | CN | disclosed |
| US-20090099382-A1 | ACTIVE INGREDIENT CARRIERS WHICH ARE BASED ON SILICON AND CONTAIN AMINOALKYL GROUPS | HENKEL AG & CO. KGAA (DE) | 2009-04-16 | — | — | US | disclosed |
| US-7098178-B2 | Silicic acid ester mixtures | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2006-08-29 | — | — | US | disclosed |
| CN-1767807-A | Transparent or translucent care and/or make-up cosmetic composition structured with silicone polymers | OREAL (FR) | 2006-05-03 | — | — | CN | disclosed |
| EP-0185526-B1 | SOLVENT SOLUBLE FLUORINE-CONTAINING POLYMER, COATING COMPOSITION CONTAINING THE SAME AND COATING PROCESS THEREOF | MITSUI SEKIYU KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-03-13 | — | — | EP | disclosed |
| US-4751114-A | COPOLYMER OF FLUOROLEFIN, VINYL ETHER AND ORGANOSILICON COMPOUND | MITSUI SEKIYU KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-06-14 | — | — | US | disclosed |
| US-4737444-A | UNDERCOATING IS POLYMER CONTAINING METAL ALCOHOLATE | RICOH COMPANY, LTD. (JP) | 1988-04-12 | — | — | US | disclosed |
| US-4701508-A | ADDITION POLYMER OF FLUOROOLEFIN, A VINYL ETHER UNSATURATED HYDROLYZABLE ESTER OF A SILANEDIOL OR-TRIOL; WEATHERPROOFING; SOLVENT RESISTANCE | MITSUI SEKIYU KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-10-20 | — | — | US | disclosed |
| EP-0185526-A2 | Solvent soluble fluorine-containing polymer, coating composition containing the same and coating process thereof | MITSUI SEKIYU KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1986-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099382-A1 | ACTIVE INGREDIENT CARRIERS WHICH ARE BASED ON SILICON AND CONTAIN AMINOALKYL GROUPS | SMYD2, SCLY, SMYD3 | TDP1 1644/4885CA1 2453/4885CA2 2449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.